{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T10:59:01Z","timestamp":1781348341909,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Cuiying Science and Technology Innovation Project","award":["Project No. CY2024-MS-B10"],"award-info":[{"award-number":["Project No. CY2024-MS-B10"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06534-7","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T10:49:18Z","timestamp":1781347758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and multicohort validation of an interpretable postoperative model for intravesical recurrence after radical nephroureterectomy in upper tract urothelial carcinoma"],"prefix":"10.1007","volume":"44","author":[{"given":"Cheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaipeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongjin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjin","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghou","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panfeng","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"6534_CR1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.eururo.2025.02.023","volume":"87","author":"A Masson-Lecomte","year":"2025","unstructured":"Masson-Lecomte A, Birtle A, Pradere B et al (2025) European Association of Urology guidelines on upper tract urothelial carcinoma: summary of the 2025 update. Eur Urol 87:697\u2013716. https:\/\/doi.org\/10.1016\/j.eururo.2025.02.023","journal-title":"Eur Urol"},{"key":"6534_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21830","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74:12\u201349. https:\/\/doi.org\/10.3322\/caac.21830","journal-title":"CA Cancer J Clin"},{"key":"6534_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00345-016-1928-x","volume":"35","author":"F Soria","year":"2017","unstructured":"Soria F, Shariat SF, Lerner SP et al (2017) Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC). World J Urol 35:379\u2013387. https:\/\/doi.org\/10.1007\/s00345-016-1928-x","journal-title":"World J Urol"},{"key":"6534_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.eururo.2012.02.030","volume":"62","author":"G Lughezzani","year":"2012","unstructured":"Lughezzani G, Burger M, Margulis V et al (2012) Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol 62:100\u2013114. https:\/\/doi.org\/10.1016\/j.eururo.2012.02.030","journal-title":"Eur Urol"},{"key":"6534_CR5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.urolonc.2009.06.003","volume":"29","author":"MD Az\u00e9mar","year":"2011","unstructured":"Az\u00e9mar MD, Comperat E, Richard F et al (2011) Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol 29:130\u2013136. https:\/\/doi.org\/10.1016\/j.urolonc.2009.06.003","journal-title":"Urol Oncol"},{"key":"6534_CR6","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.eururo.2013.09.003","volume":"65","author":"E Xylinas","year":"2014","unstructured":"Xylinas E, Kluth L, Passoni N et al (2014) Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool. Eur Urol 65:650\u2013658. https:\/\/doi.org\/10.1016\/j.eururo.2013.09.003","journal-title":"Eur Urol"},{"key":"6534_CR7","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.eururo.2014.11.035","volume":"67","author":"T Seisen","year":"2015","unstructured":"Seisen T, Granger B, Colin P et al (2015) A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma. Eur Urol 67:1122\u20131133. https:\/\/doi.org\/10.1016\/j.eururo.2014.11.035","journal-title":"Eur Urol"},{"key":"6534_CR8","doi-asserted-by":"publisher","first-page":"11223","DOI":"10.1007\/s00432-023-05016-2","volume":"149","author":"Z Luo","year":"2023","unstructured":"Luo Z, Jiao B, Huang T et al (2023) Development and external validation of a novel nomogram to predict intravesical recurrence after radical nephroureterectomy: a multicenter study. J Cancer Res Clin Oncol 149:11223\u201311231. https:\/\/doi.org\/10.1007\/s00432-023-05016-2","journal-title":"J Cancer Res Clin Oncol"},{"key":"6534_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/cancers16010044","volume":"16","author":"J Klemm","year":"2023","unstructured":"Klemm J, Bekku K, Abufaraj M et al (2023) Upper tract urothelial carcinoma: a narrative review of current surveillance strategies for non-metastatic disease. Cancers (Basel) 16:44. https:\/\/doi.org\/10.3390\/cancers16010044","journal-title":"Cancers (Basel)"},{"key":"6534_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5489\/cuaj.5377","volume":"12","author":"JA Locke","year":"2018","unstructured":"Locke JA, Hamidizadeh R, Kassouf W et al (2018) Surveillance guidelines based on recurrence patterns for upper tract urothelial carcinoma. Can Urol Assoc J 12:243\u2013251. https:\/\/doi.org\/10.5489\/cuaj.5377","journal-title":"Can Urol Assoc J"},{"key":"6534_CR11","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.euo.2019.06.021","volume":"3","author":"K Shigeta","year":"2020","unstructured":"Shigeta K, Kikuchi E, Abe T et al (2020) A novel risk-based approach simulating oncological surveillance after radical nephroureterectomy in patients with upper tract urothelial carcinoma. Eur Urol Oncol 3:756\u2013763. https:\/\/doi.org\/10.1016\/j.euo.2019.06.021","journal-title":"Eur Urol Oncol"},{"key":"6534_CR12","doi-asserted-by":"publisher","first-page":"23047","DOI":"10.18632\/oncotarget.25198","volume":"9","author":"M Momota","year":"2018","unstructured":"Momota M, Hatakeyama S, Yamamoto H et al (2018) Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma. Oncotarget 9:23047\u201323057. https:\/\/doi.org\/10.18632\/oncotarget.25198","journal-title":"Oncotarget"},{"key":"6534_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00345-012-0957-3","volume":"31","author":"E Xylinas","year":"2013","unstructured":"Xylinas E, Colin P, Audenet F et al (2013) Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study. World J Urol 31:61\u201368. https:\/\/doi.org\/10.1007\/s00345-012-0957-3","journal-title":"World J Urol"},{"key":"6534_CR14","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche P, Dartigues JF, Jacqmin-Gadda H (2013) Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med 32:5381\u20135397. https:\/\/doi.org\/10.1002\/sim.5958","journal-title":"Stat Med"},{"key":"6534_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB (2006) Decision curve analysis: a novel method for evaluating prediction models. Med Decis Mak 26:565\u2013574. https:\/\/doi.org\/10.1177\/0272989X06295361","journal-title":"Med Decis Mak"},{"key":"6534_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jclinepi.2015.12.005","volume":"74","author":"B Van Calster","year":"2016","unstructured":"Van Calster B, Nieboer D, Vergouwe Y et al (2016) A calibration hierarchy for risk models was defined: from utopia to empirical data. J Clin Epidemiol 74:167\u2013176. https:\/\/doi.org\/10.1016\/j.jclinepi.2015.12.005","journal-title":"J Clin Epidemiol"},{"key":"6534_CR17","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1002\/sim.7501","volume":"36","author":"PC Austin","year":"2017","unstructured":"Austin PC, Fine JP (2017) Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Stat Med 36:4391\u20134400. https:\/\/doi.org\/10.1002\/sim.7501","journal-title":"Stat Med"},{"key":"6534_CR18","doi-asserted-by":"publisher","first-page":"g7594","DOI":"10.1136\/bmj.g7594","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG et al (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ 350:g7594. https:\/\/doi.org\/10.1136\/bmj.g7594","journal-title":"BMJ"},{"key":"6534_CR19","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj.q902","volume":"385","author":"GS Collins","year":"2024","unstructured":"Collins GS, Moons KGM, Dhiman P et al (2024) TRIPOD\u2009+\u2009AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ 385:e078378. https:\/\/doi.org\/10.1136\/bmj.q902","journal-title":"BMJ"},{"key":"6534_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.urology.2007.08.054","volume":"71","author":"T Terakawa","year":"2008","unstructured":"Terakawa T, Miyake H, Muramaki M et al (2008) Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract. Urology 71:123\u2013127. https:\/\/doi.org\/10.1016\/j.urology.2007.08.054","journal-title":"Urology"},{"key":"6534_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10147-016-1040-7","volume":"22","author":"N Kishimoto","year":"2017","unstructured":"Kishimoto N, Takao T, Kuribayashi S et al (2017) The neutrophil-to-lymphocyte ratio as a predictor of intravesical recurrence in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. Int J Clin Oncol 22:153\u2013158. https:\/\/doi.org\/10.1007\/s10147-016-1040-7","journal-title":"Int J Clin Oncol"},{"key":"6534_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.clgc.2016.12.027","volume":"15","author":"M Marchioni","year":"2017","unstructured":"Marchioni M, Cindolo L, Autorino R et al (2017) High neutrophil-to-lymphocyte ratio as prognostic factor in patients affected by upper tract urothelial cancer: a systematic review and meta-analysis. Clin Genitourin Cancer 15:343\u2013349e341. https:\/\/doi.org\/10.1016\/j.clgc.2016.12.027","journal-title":"Clin Genitourin Cancer"},{"key":"6534_CR23","doi-asserted-by":"publisher","first-page":"189e1","DOI":"10.1016\/j.urolonc.2024.11.015","volume":"43","author":"R Contieri","year":"2025","unstructured":"Contieri R, Claps F, Hurle R, Buffi NM, Lughezzani G, Lazzeri M et al (2025) Impact of smoking exposure on disease progression in high risk and very high-risk nonmuscle invasive bladder cancer patients undergoing BCG therapy. Urol Oncol 43:189e1\u2013189e8. https:\/\/doi.org\/10.1016\/j.urolonc.2024.11.015","journal-title":"Urol Oncol"},{"key":"6534_CR24","doi-asserted-by":"publisher","first-page":"338","DOI":"10.23736\/S2724-6051.24.05876-2","volume":"77","author":"M Ferro","year":"2025","unstructured":"Ferro M, Tataru OS, Fallara G, Fiori C, Manfredi M, Claps F et al (2025) Assessing the influence of smoking on inflammatory markers in bacillus Calmette\u2013Gu\u00e9rin response among bladder cancer patients: a novel machine-learning approach. Minerva Urol Nephrol 77:338\u2013346. https:\/\/doi.org\/10.23736\/S2724-6051.24.05876-2","journal-title":"Minerva Urol Nephrol"},{"key":"6534_CR25","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3390\/medicina59050926","volume":"59","author":"F Claps","year":"2023","unstructured":"Claps F, Rossin G, van Rhijn BWG, Mir MC, Mertens LS, Ongaro L et al (2023) The utility of inflammatory serum markers in the assessment of perioperative morbidity after radical cystectomy for bladder cancer. Med (Kaunas) 59:926. https:\/\/doi.org\/10.3390\/medicina59050926","journal-title":"Med (Kaunas)"},{"key":"6534_CR26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.eururo.2022.07.002","volume":"82","author":"GJ Netto","year":"2022","unstructured":"Netto GJ, Amin MB, Berney DM et al (2022) The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. Eur Urol 82:469\u2013482. https:\/\/doi.org\/10.1016\/j.eururo.2022.07.002","journal-title":"Eur Urol"},{"key":"6534_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2026.02.009","author":"RAG Lijnen","year":"2026","unstructured":"Lijnen RAG, Ringia JB, Claps F et al (2026) Diagnostic value of fluorine-18-fluorodeoxyglucose positron emission tomography\/computed tomography in staging histological subtypes of invasive bladder cancer. Eur Urol Oncol. https:\/\/doi.org\/10.1016\/j.euo.2026.02.009","journal-title":"Eur Urol Oncol"},{"key":"6534_CR28","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.3390\/jcm13154349","volume":"13","author":"F Claps","year":"2024","unstructured":"Claps F, Biasatti A, Di Gianfrancesco L et al (2024) The prognostic significance of histological subtypes in patients with muscle-invasive bladder cancer: an overview of the current literature. J Clin Med 13:4349. https:\/\/doi.org\/10.3390\/jcm13154349","journal-title":"J Clin Med"},{"key":"6534_CR29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/bju.15984","volume":"132","author":"F Claps","year":"2023","unstructured":"Claps F, van de Kamp MW, Mayr R et al (2023) Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy. BJU Int 132:170\u2013180. https:\/\/doi.org\/10.1111\/bju.15984","journal-title":"BJU Int"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06534-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06534-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06534-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T10:49:19Z","timestamp":1781347759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06534-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6534"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06534-7","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted under institutional ethics oversight at the Second Hospital of Lanzhou University and in accordance with the Declaration of Helsinki and relevant national regulations. The current approval\/update record is archived under No. 2026\u00a0A-533.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The requirement for written informed consent was waived by the institutional ethics committee because this observational study involved only the collection and analysis of anonymized clinical data and did not alter routine treatment or introduce additional interventions.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"425"}}